• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加速性伴治疗:明尼苏达州减少性传播疾病的新策略。

Expedited partner therapy: a new strategy for reducing sexually transmitted diseases in Minnesota.

作者信息

Hadsall Candy, Riedesel Melissa, Carr Peter, Lynfield Ruth

机构信息

STD and HIV Section, Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, USA.

出版信息

Minn Med. 2009 Oct;92(10):55-7.

PMID:19916276
Abstract

Chlamydia and gonorrhea are the two most commonly reported communicable diseases in Minnesota and the United States. Treatment of sexual partners is essential for control and prevention of these and other sexually transmitted diseases (STDs). However, traditional strategies for getting partners into treatment such as patient referral, physician referral, or referral from the health department are not always successful. Expedited partner therapy (EPT) is the practice of treating the sexual partners of persons with STDs without medical evaluation. This article describes the evidence that EPT reduces persistent chlamydial and gonococcal infections and the Centers for Disease Control and Prevention's recommendations for EPT for heterosexual partners of patients with chlamydia and/or gonorrhea. It also addresses legislation that removed the last-known legal barrier to EPT in Minnesota as well as concerns about implementation of this treatment strategy.

摘要

衣原体感染和淋病是明尼苏达州及美国报告最多的两种传染病。治疗性伴侣对于控制和预防这些及其他性传播疾病至关重要。然而,传统的促使伴侣接受治疗的策略,如患者转诊、医生转诊或卫生部门转诊,并不总是成功的。加速性伴侣治疗(EPT)是指在不进行医学评估的情况下,对患有性传播疾病者的性伴侣进行治疗的做法。本文介绍了加速性伴侣治疗可减少衣原体和淋病持续感染的证据,以及疾病控制与预防中心针对衣原体和/或淋病患者异性性伴侣的加速性伴侣治疗建议。文章还讨论了消除明尼苏达州加速性伴侣治疗最后一个已知法律障碍的立法,以及对这种治疗策略实施情况的担忧。

相似文献

1
Expedited partner therapy: a new strategy for reducing sexually transmitted diseases in Minnesota.加速性伴治疗:明尼苏达州减少性传播疾病的新策略。
Minn Med. 2009 Oct;92(10):55-7.
2
Expedited partner therapy for adolescents diagnosed with gonorrhea or chlamydia: a review and commentary.针对被诊断为淋病或衣原体感染的青少年的加速性伴侣治疗:综述与评论。
Adolesc Med Clin. 2006 Oct;17(3):687-95; abstract xii. doi: 10.1016/j.admecli.2006.06.005.
3
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.性伴侣快速治疗对复发性或持续性淋病或衣原体感染的影响。
N Engl J Med. 2005 Feb 17;352(7):676-85. doi: 10.1056/NEJMoa041681.
4
A qualitative study of patients' use of expedited partner therapy.一项关于患者使用加速性伴侣治疗的定性研究。
Sex Transm Dis. 2011 Jul;38(7):651-6. doi: 10.1097/OLQ.0b013e31820cb206.
5
Strategies for partner management when treating sexually transmitted infection.性传播感染治疗中的伴侣管理策略。
J Midwifery Womens Health. 2011 Nov-Dec;56(6):608-14. doi: 10.1111/j.1542-2011.2011.00087.x. Epub 2011 Sep 23.
6
California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae.加利福尼亚州沙眼衣原体和淋病奈瑟菌加速性伴侣治疗指南。
Sex Transm Dis. 2008 Mar;35(3):314-9. doi: 10.1097/OLQ.0b013e31815b0158.
7
The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea.加速性伴侣治疗与标准性伴侣转介治疗衣原体或淋病的成本及成本效益比较。
Sex Transm Dis. 2011 Nov;38(11):1067-73. doi: 10.1097/OLQ.0b013e31822e9192.
8
Implementation and effectiveness of an expedited partner therapy program in an urban clinic.加速性伴侣治疗方案在城市诊所的实施和效果。
Sex Transm Dis. 2012 Dec;39(12):923-9. doi: 10.1097/OLQ.0b013e3182756f20.
9
Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.患者主导的性伴治疗男性尿道炎:一项随机对照试验。
Clin Infect Dis. 2005 Sep 1;41(5):623-9. doi: 10.1086/432476. Epub 2005 Jul 19.
10
Concurrent patient-partner treatment in pregnancy: an alternative to expedited partner therapy?妊娠期间同时对患者及其伴侣进行治疗:是否可替代加速的伴侣治疗?
Sex Transm Dis. 2012 Sep;39(9):665-70. doi: 10.1097/OLQ.0b013e318259f5a4.